Importance of iron chelation therapy

by A. Varoğlu
Published 2011-12-01

Complexing treatment efficacy as measured by methyl mercury distribution and toxic signs

by Zimmer, Louis John, 1947-
Published 1978

Manganese and Movement Disorders: A Review

by Dinkar Kulshreshtha, Jacky Ganguly, Mandar Jog
Published 2021-05-01

Investigation of immobilized biopolymers for metal binding

by Malachowski, Lisa Lyn
Published 2008

Management of Iron Overload in Beta-Thalassemia Patients: Clinical Practice Update Based on Case Series

by Valeria Maria Pinto, Gian Luca Forni
Published 2020-11-01

Lens opacity as a serious side effect following chelation therapy in beta thalassemia: A comparison between deferoxamine and deferasirox; randomized double-blinded clinical trial

by Mohammad Reza Golpayegani, Vahid Falahati, Sam Habibollahi Habibollahi, Mahsa Fallahi
Published 2019-01-01

THE USE OF A CHELATING AGENT AS AN ANTAGONIST TO THE CARDIAC TOXICITY OF OLEANDRIN

by Burton, Lloyd Edward, 1922-
Published 1964

The Disturbed Iron Phenotype of Tumor Cells and Macrophages in Renal Cell Carcinoma Influences Tumor Growth

by Matthias Schnetz, Julia K. Meier, Claudia Rehwald, Christina Mertens, Anja Urbschat, Elisa Tomat, Eman A. Akam, Patrick Baer, Frederik C. Roos, Bernhard Brüne, Michaela Jung
Published 2020-02-01

EDTA Chelation Therapy in the Treatment of Neurodegenerative Diseases: An Update

by Alessandro Fulgenzi, Daniele Vietti, Maria Elena Ferrero
Published 2020-08-01

Regular Reminding of the Potential Serious Complications of Poor Adherence to Treatment: A Strategy for Improving Treatment Adherence in Beta-Thalassemia Major Patients

by Amir Emami Zeydi, Abbas Heydari, Hossein Karimi Moonaghi
Published 2017-12-01

Evaluation of a new tablet formulation of deferasirox to reduce chronic iron overload after long-term blood transfusions

by Chalmers AW, Shammo JM
Published 2016-02-01

Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports

by Lena H. P. Vroegindeweij, Agnita J. W. Boon, J. H. Paul Wilson, Janneke G. Langendonk
Published 2020-04-01

MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY

by Emanuele Angelucci, Silvana Anna Maria Urru, Federica Pilo, Alberto Piperno
Published 2017-03-01

Successful management of acute bismuth intoxication complicated with acute renal failure, seizures and acute pancreatitis in a child

by Aydın Ece, Zeki Tünay
Published 2018-09-01

Overview of chelation recommendations for thalassaemia and sickle cell disease

by Banu Kaya
Published 2014-12-01

Effect of Chelation Therapy on Lead-induced Hepatotoxicity: A Case Series

by Faezeh Shadfar, Zakaria Zakariaei, Seyed Khosro Ghasempoori, Mahmood Moosazadeh, Navid Khosravi
Published 2019-07-01

Role of iron metabolism genetic determinants in response to chelation therapy in a cohort of β-thalassemia and sickle cell syndromes Italian patients

by Maria Concetta Renda, Disma Renda, Angela Piazza, Giuseppina Calvaruso, Emanuela Fecarotta, Antonino Giangreco, Aurelio Maggio
Published 2014-09-01

Current Biomedical Use of Copper Chelation Therapy

by Silvia Baldari, Giuliana Di Rocco, Gabriele Toietta
Published 2020-02-01

Urinary neutrophil gelatinase-associated lipocalin as a marker of kidney injury in Egyptian patients with thalassemia

by Ibrahim Z Fouad, Maggie S ElNahid, Maha F Youssef, Yasmine M Amroussy
Published 2019-01-01

Frequency of Glomerular Dysfunction in Children with Beta Thalassaemia Major

by Basma A. Ali, Ahmed M. Mahmoud
Published 2014-02-01